The life expectancy of female thyroid cancer patients is related to the patients’ pathology, overall treatment plan and physical condition, and even some patients’ life expectancy is not much different from that of normal people after receiving regular treatment.
At present, the cause of thyroid cancer is still unclear, early patients may have no obvious symptoms, with the development of the disease appeared compression symptoms, such as compression of organs, esophageal displacement and so on.
Clinically, the prognosis of papillary thyroid cancer and follicular thyroid cancer is relatively good, and they can even survive for a long time after receiving treatment, which does not have a great impact on life expectancy; medullary thyroid cancer is not as good as the first two types of cancer because it is often accompanied by lymphatic invasion and hematogenous metastasis, and the median survival time of undifferentiated carcinoma, although it is rare in the clinic, has been reported to be only 7-10 months due to the high degree of malignancy.
Female thyroid cancer patients can reduce the adverse effects of the disease through “early detection, early diagnosis and early treatment”, and many patients may survive for a long time, so it is recommended that patients establish confidence in treatment.
Thyroid cancer should be treated actively after diagnosis, and levothyroxine tablets need to be taken as replacement therapy after surgery. Therefore, it is necessary to check the level of thyroxine regularly after the surgery, and to review whether there is any recurrence of thyroid cancer regularly.